Have any questions? 706-721-6582 or cts@augusta.edu
This study is for kidney transplant patients have not had CMV infection. These patients have received a kidney from a donor who has tested positive for CMV infection. This puts them at great risk for getting CMV infection. This study will test the safety and effects of a new drug in treating and preventing cytomegalyvirus (CMV) infections in these patients.